Stockreport

Silence Therapeutics plc (NASDAQ:SLN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report [Yahoo! Finance]

Silence Therapeutics Plc - American Depository Share  (SLN) 
PDF Statutory earnings fell substantially short of expectations, with revenues of UK£598k missing forecasts by 94%. Losses exploded, with a per-share loss of UK£0.34 some 35 [Read more]